Jiangsu Bioperfectus Technologies Co Ltd
SSE:688399
Income Statement
Earnings Waterfall
Jiangsu Bioperfectus Technologies Co Ltd
Revenue
|
1.5B
CNY
|
Cost of Revenue
|
-612.6m
CNY
|
Gross Profit
|
905.1m
CNY
|
Operating Expenses
|
-901.7m
CNY
|
Operating Income
|
3.5m
CNY
|
Other Expenses
|
24.1m
CNY
|
Net Income
|
27.5m
CNY
|
Income Statement
Jiangsu Bioperfectus Technologies Co Ltd
Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||
Revenue |
263
N/A
|
289
+10%
|
436
+51%
|
739
+70%
|
1 199
+62%
|
1 740
+45%
|
2 396
+38%
|
2 298
-4%
|
2 811
+22%
|
2 839
+1%
|
3 504
+23%
|
4 974
+42%
|
4 961
0%
|
5 535
+12%
|
4 107
-26%
|
2 455
-40%
|
1 518
-38%
|
|
Gross Profit | ||||||||||||||||||
Cost of Revenue |
(48)
|
(53)
|
(68)
|
(126)
|
(233)
|
(391)
|
(606)
|
(609)
|
(808)
|
(880)
|
(1 217)
|
(1 899)
|
(1 982)
|
(2 380)
|
(1 688)
|
(968)
|
(613)
|
|
Gross Profit |
215
N/A
|
236
+10%
|
368
+56%
|
613
+67%
|
967
+58%
|
1 349
+40%
|
1 790
+33%
|
1 689
-6%
|
2 003
+19%
|
1 959
-2%
|
2 288
+17%
|
3 076
+34%
|
2 979
-3%
|
3 155
+6%
|
2 419
-23%
|
1 487
-39%
|
905
-39%
|
|
Operating Income | ||||||||||||||||||
Operating Expenses |
(135)
|
(146)
|
(178)
|
(209)
|
(268)
|
(418)
|
(523)
|
(535)
|
(590)
|
(618)
|
(665)
|
(883)
|
(917)
|
(922)
|
(1 122)
|
(931)
|
(902)
|
|
Selling, General & Administrative |
(108)
|
(100)
|
(143)
|
(174)
|
(228)
|
(363)
|
(485)
|
(489)
|
(535)
|
(534)
|
(592)
|
(739)
|
(705)
|
(758)
|
(629)
|
(495)
|
(512)
|
|
Research & Development |
(34)
|
(37)
|
(44)
|
(49)
|
(58)
|
(70)
|
(77)
|
(82)
|
(90)
|
(102)
|
(117)
|
(175)
|
(213)
|
(178)
|
(193)
|
(149)
|
(117)
|
|
Depreciation & Amortization |
0
|
(16)
|
0
|
0
|
0
|
(20)
|
0
|
0
|
0
|
(31)
|
0
|
0
|
0
|
(60)
|
0
|
0
|
0
|
|
Other Operating Expenses |
7
|
6
|
9
|
14
|
18
|
35
|
39
|
37
|
35
|
49
|
45
|
31
|
1
|
74
|
(300)
|
(287)
|
(273)
|
|
Operating Income |
79
N/A
|
90
+13%
|
190
+111%
|
404
+113%
|
699
+73%
|
931
+33%
|
1 267
+36%
|
1 154
-9%
|
1 412
+22%
|
1 341
-5%
|
1 623
+21%
|
2 192
+35%
|
2 062
-6%
|
2 233
+8%
|
1 297
-42%
|
556
-57%
|
3
-99%
|
|
Pre-Tax Income | ||||||||||||||||||
Interest Income Expense |
4
|
5
|
11
|
16
|
22
|
25
|
27
|
26
|
27
|
51
|
53
|
59
|
62
|
55
|
88
|
80
|
82
|
|
Non-Reccuring Items |
1
|
0
|
1
|
1
|
3
|
7
|
6
|
6
|
6
|
3
|
4
|
4
|
3
|
(137)
|
2
|
2
|
3
|
|
Gain/Loss on Disposition of Assets |
0
|
(0)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
|
Total Other Income |
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(4)
|
(3)
|
(3)
|
(5)
|
(3)
|
(7)
|
(10)
|
(10)
|
(11)
|
|
Pre-Tax Income |
84
N/A
|
95
+13%
|
201
+112%
|
421
+110%
|
723
+72%
|
961
+33%
|
1 298
+35%
|
1 184
-9%
|
1 440
+22%
|
1 392
-3%
|
1 677
+20%
|
2 251
+34%
|
2 125
-6%
|
2 139
+1%
|
1 376
-36%
|
628
-54%
|
78
-88%
|
|
Net Income | ||||||||||||||||||
Tax Provision |
(10)
|
(11)
|
(27)
|
(60)
|
(107)
|
(141)
|
(195)
|
(170)
|
(206)
|
(199)
|
(240)
|
(326)
|
(303)
|
(311)
|
(199)
|
(102)
|
(50)
|
|
Income from Continuing Operations |
74
|
84
|
174
|
361
|
616
|
820
|
1 103
|
1 014
|
1 234
|
1 193
|
1 437
|
1 925
|
1 821
|
1 828
|
1 177
|
526
|
28
|
|
Net Income (Common) |
74
N/A
|
84
+13%
|
174
+108%
|
361
+108%
|
616
+70%
|
820
+33%
|
1 103
+35%
|
1 014
-8%
|
1 234
+22%
|
1 193
-3%
|
1 437
+20%
|
1 925
+34%
|
1 821
-5%
|
1 828
+0%
|
1 177
-36%
|
526
-55%
|
28
-95%
|
|
EPS (Diluted) |
1.69
N/A
|
1.85
+9%
|
2.96
+60%
|
6.16
+108%
|
10.5
+70%
|
13.98
+33%
|
18.83
+35%
|
17.31
-8%
|
21.05
+22%
|
20.36
-3%
|
24.52
+20%
|
32.83
+34%
|
31.07
-5%
|
31.18
+0%
|
20.08
-36%
|
8.98
-55%
|
0.47
-95%
|